STARING down at the scales in devastation, Karen Lay wondered if her body was “broken” as the fat jabs she had used for the ...
Sen. John Kennedy of Louisiana is taking aim at California’s Medicaid program for providing housing assistance, food, and ...
New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach ...
A novel plasmid-based immunotherapy was safe and well tolerated among adults with type 1 diabetes autoantibodies, according ...
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational ...
New research presented today at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an ...
Ten-year results show a single CAR T infusion can keep many patients with aggressive and slow-growing B-cell lymphomas cancer-free, pointing toward true long-term cures.
Morning Overview on MSN
A new daily pill beat oral Ozempic for weight loss and blood sugar in a major diabetes trial
Eli Lilly’s once-daily oral pill orforglipron outperformed oral semaglutide in reducing blood sugar and body weight over 52 ...
MedPage Today on MSN
Study Dampens Hope for GLP-1s as Insulin Off-Ramp in Type 2 Diabetes
No difference in insulin discontinuation rates seen among three glucose-lowering classes ...
Alexander Zverev’s medical condition was a slight issue at the French Open 2026, when he paused to check his blood sugar levels. But he overcame the diagnosis to win the French Open, his first Grand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results